- 专利标题： Dynactin subunit p62 biomarker for neurological conditions
-
申请号： US13457352申请日： 2012-04-26
-
公开(公告)号： US09746458B2公开(公告)日： 2017-08-29
- 发明人: Wolff M. Kirsch , Matthew Schrag , Andrew Crofton , Matthew Zabel , Claudius Mueller
- 申请人： Wolff M. Kirsch , Matthew Schrag , Andrew Crofton , Matthew Zabel , Claudius Mueller
- 申请人地址： US CA Loma Linda
- 专利权人： Loma Linda University Medical Center
- 当前专利权人： Loma Linda University Medical Center
- 当前专利权人地址： US CA Loma Linda
- 代理机构： Knobbe Martens Olson & Bear LLP
- 主分类号： G01N33/50
- IPC分类号： G01N33/50 ; G01N33/566 ; G01N33/84
摘要：
Methods and kits for identifying neurological conditions in a patient by determining a level of expression of dynactin subunit p62 are disclosed. The neurological conditions may include, for example, Alzheimer's Disease (AD) without cerebral amyloid angiopathy (CAA).
公开/授权文献
信息查询
IPC分类:
